Germany· DE-A57-6b9babc5917f8083
Zevtera
A medicinal product containing ceftobiprole medocaril sodium, registered in Germany by Advanz Pharma Limited.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ceftobiprole Medocaril Sodium
- Manufacturer
- Advanz Pharma Limited
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftobiprole medocaril sodium in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesZEVTERALa Jolla Pharmaceutical Company
- FinlandZevteraBasilea Pharmaceutica Deutschland GmbH
- FranceMABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusionADVANZ PHARMA LIMITED
- BelgiumMabelio 500 mgBasilea Medical
- NorwayZevteraBasilea Pharmaceutica Deutschland GmbH
- SwedenZevtera 500 mg Pulver till koncentrat till infusionsvätska, lösningBasilea Pharmaceutica Deutschland GmbH
- IrelandAdaluzis 500mg Powder for concentrate for solution for infusionAdvanz Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Zevtera
- Denmark · Zevtera
- Spain · Zevtera
- Finland · Zevtera
- France · Mabelio
- United Kingdom (Northern Ireland) · Zevtera
- Ireland · Adaluzis
- Italy · Mabelio
- Luxembourg · Mabelio, Zevtera
- Norway · Zevtera
- Poland · Zevtera
- Portugal · Zevtera
- Sweden · Zevtera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1eca8cf3-58ab-44a1-8b33-53a11f0b5cbe GET /v1/drugs/1eca8cf3-58ab-44a1-8b33-53a11f0b5cbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ceftobiprole Medocaril Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ceftobiprole medocaril sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.